Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 21;219(1):uxaf017.
doi: 10.1093/cei/uxaf017.

Mimics and challenging presentations of DADA2

Affiliations
Review

Mimics and challenging presentations of DADA2

Admir Öztürk et al. Clin Exp Immunol. .

Abstract

Deficiency of adenosine deaminase 2 (DADA2) has been a challenging diagnosis to make since it was first described in 2014. The disease represents a wide range of phenotypes. Therefore, it may present with various clinical patterns. Throughout the years, several difficult-to-diagnose cases of DADA2 were reported in the literature. Although several studies and reviews were published regarding different phenotypes and manifestations of DADA2, a review of challenging cases with diverse combinations of DADA2 manifestations was needed to integrate the knowledge from the literature into the clinical practice. Immunological, hematologic, autoinflammatory, and adult-onset polyarteritis-nodosa patterns were reported in the literature as cases challenging to diagnose. In this review, we aim to summarize the challenging case reports from the literature, provide an algorithmic approach for these kinds of presentations, and share our perspective and recommendations on the topic. Diagnosing DADA2 on time is a vital issue for preventing fatal and debilitating vascular events with anti-TNF-alpha therapy. Thus, early testing for DADA2 in suspected cases is recommended. Family history and genetic testing of the patient and the first-degree relatives are essential for accurate diagnosis. Thorough systemic examination and imaging might help detect clinically silent findings of vasculitis. Enzymatic activity of ADA2, when available, is also a key diagnostic tool that complements genetic testing and clinical evaluation.

Keywords: autoinflammatory disease; immunodeficiency diseases; inflammation; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Signa S, Bertoni A, Penco F, Caorsi R, Cafaro A, Cangemi G, et al.Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity. Front Immunol 2022, 13, 935957. doi: https://doi.org/10.3389/fimmu.2022.935957. - DOI - PMC - PubMed
    1. Sharma V, Deo P, Sharma A.. Deficiency of adenosine deaminase 2 (DADA2): review. Best Pract Res Clin Rheumatol 2023, 37, 101844. doi: https://doi.org/10.1016/j.berh.2023.101844 - DOI - PubMed
    1. Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al.Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 2014, 370, 921–31. doi: https://doi.org/10.1056/NEJMoa1307362 - DOI - PubMed
    1. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al.Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014, 370, 911–20. doi: https://doi.org/10.1056/NEJMoa1307361 - DOI - PMC - PubMed
    1. Meyts I, Aksentijevich I.. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol 2018, 38, 569–78. doi: https://doi.org/10.1007/s10875-018-0525-8 - DOI - PMC - PubMed

MeSH terms

Substances

Supplementary concepts